Apr 032020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and improve human health, today announced the appointment of Anne Prener, M.D., Ph.D., to its Board of Directors. Dr. Prener has more than 25 years ...

Kaleido Biosciences welcomes Dr Anne Prener to its Board of Directors

Kaleido Biosciences welcomes Dr Anne Prener to its Board of Directors

From:: Kaleido Biosciences welcomes Dr Anne Prener to its Board of Directors

Sorry, the comment form is closed at this time.